HEOR Presentations

ISPOR

ISPOR 18th Annual European Congress; Milan, Italy 2015

 


ERA-EDTA

ERA-EDTA 52nd Congress; London, UK 2015

 


Robinson P, McEwan P, Ong ACM, Ørskov B, Sandford R, Scolari F, Walz G, Bennett Wilton H, O’Reilly K. Assessing the long term outcomes of Autosomal Dominant Polycystic Kidney Disease (ADPKD) using the ADPKD Outcomes Model: a UK case study

Robinson P, Bennett Wilton H, McEwan P, O’Reilly K. Exploring the impact of tolvaptan on the long term rate of renal function decline using the ADPKD Outcomes Model

ISPOR

ISPOR 20th Annual International Meeting; Philadelphia, Pennsylvania, USA 2015


Diabetes UK

Diabetes UK Professional Conference 2015; London, UK 2015


Evans M, Wolden ML, Thorsted BL, McEwan PC, Jacobsen JL. Inpatient hypoglycaemia increases length of hospital stay and all-cause mortality risk

APASL

24th Asian Pacific Association for the Study of the Liver; Istanbul, Turkey 2015


Kim DY, Han K, Jun B, Kim TH, Park S, Ward T, Webster S, McEwan P. Cost-effectiveness of one time screening for HCV in South Korea

ADA

75th Scientific Sessions of the American Diabetes Association (ADA); Massacheusetts, USA 2015


McEwan P, Ward T, Webster S, Kalsekar A, Brenner M, Yuan Y. Factors predictive of weight gain and implications for diabetes modelling: a study in T2DM patients initiaing metformin and sulphonylurea combination therapy

Mount Hood

The Mount Hood 2014 Challenge; Stanford, CA, USA 2014


McEwan P. Validating The UKPDS 68 And 82 Risk Equations To Contemporary Outcomes Studies In Type 2 Diabetes

McEwan P. Quantifying Nonlinear Effects In Stochastic Markov Simulation Using UKPDS 68 And UKPDS 82 Equations In Type 2 Diabetes Modeling Analysis With The IMS Core Diabetes Model (CDM)

McEwan P. Comparing The Use Of Patient Level Data To An Average Patient Profile Within A Type 2 Diabetes Simulation Model

APASL

23rd Asian Pacific Association for the Study of the Liver; Brisbane, Australia 2014


Kamae I, Ward T, Webster S, Kobayashi M, McEwan P, Yuan Y, Kalsekar A, Inoue S, Tang A, Kumada H. Estimating The Long-Term Clinical Effectiveness Of Daclatasvir Plus Asunaprevir In Japanese Patients Chronically Infected With HCV Genotype 1b: A Subgroup Analysis

Kamae I, Ward T, Webster S, Kobayashi M, McEwan P, Kalsekar A, Yuan Y, Inoue S, Tang A, Kumada H. Investigating Treatment Strategies To Optimise Clinical Outcomes Associated With Emerging Therapies For HCV

ERA-EDTA

ERA-EDTA 51st Congress; Amsterdam, The Netherlands 2014


Robinson P, McEwan P, Hadimeri H, Ong ACM, Ørskov B, Peces R, Sandford R, Scolari F, Walz G, Cooke C, O’Reilly K. Development of a model to predict disease progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

ISPOR

ISPOR 16th Annual European Congress; Dublin, Ireland 2013


BTS

Joint British Transplantation Society and Renal Association Meeting; Bournemouth UK 2013


McEwan P, Ward T, Righetti C, Lebmeier M. Assessing The Relationship Between Renal Allograft Survival Time, Cost And Transplant Waiting Time In The UK

ISPHC

9th International Society on Priorities in Health Care; Vancouver, Canada 2012


Gordon J, Willis C, Mitton C, Best A. Understanding Change In The Health Systems: Tools For Promoting Co-Production In Large System Transformation

ESOT

Joint European Society for Organ Transplantation and American Society of Transplantation meeting; Nice, France 2012


McEwan P, Lebmeier M. Evaluating The Minimum Renal Allograft Survival Time Required For Transplantation To Remain Cost Saving In The UK

EASL

International Liver Congress™ 2012, 47th annual meeting of the European Association for the Study of the Liver; Barcelona, Spain 2012


APASL

22nd Asian Pacific Association for the Study of the Liver; Taipei, Taiwan 2012


McEwan P, Chen C, Lee M, Yang H, Kim R, L'italien G, Yuan Y. Estimating The Incidence And Prevalence Of Hepatitis C Infection In Taiwan Using Backprojection Methods

ISPOR

ISPOR 13th Annual European Congress; Prague, Czech Republic 2010